首页> 外文会议>Conference on Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems Ⅻ Jan 19-20, 22, 2002 San Jose, USA >Preclinical evaluation of 5-ALA based PDT for the treatment of canine urinary bladder cancer: fluorescence distribution and response of normal urinary bladder tissue
【24h】

Preclinical evaluation of 5-ALA based PDT for the treatment of canine urinary bladder cancer: fluorescence distribution and response of normal urinary bladder tissue

机译:基于5-ALA的PDT治疗犬膀胱癌的临床前评价:正常膀胱组织的荧光分布和反应

获取原文
获取原文并翻译 | 示例

摘要

Photodynamic therapy (PDT) is a potential improvement over conventional therapy for urinary bladder cancer, especially using the pro-photosensitizer 5-aminolevulinic acid (ALA), which is metabolized to its active form, protoporphyrin IX (PpIX), within both normal and neoplastic epithelial tissue. The purpose of this study was to evaluate ALA-based PDT in healthy dogs as a prelude to treating dogs with transitional cell carcinoma of the urinary bladder. Methods: Twelve dogs were given oral ALA at 0, 30, 60, or 90 mg/kg. Four hours later, the dogs were sacrificed and bladder tissue was collected and frozen for low-intensity fluorescence microscopy. Fifteen dogs were given oral ALA at 0, 30, 60, or 90 mg/kg and anesthetized four hours later. The trigone was irradiated with 635 nm laser light. All dogs were necropsied after PDT (48 h or 21 d). Results: PpIX fluorescence was confined to the urinary bladder mucosa with no detectable fluorescence in the muscularis or serosa. Histopathological lesions after PDT were limited to mild inflammation. Conclusions: Oral ALA appears to be well tolerated by healthy dogs at the dosages used. Because PpIX fluorescence was confined to the mucosa, ALA-based PDT may be a useful treatment for canine lower urinary tract neoplasia.
机译:光动力疗法(PDT)是对膀胱癌常规疗法的潜在改进,尤其是使用光敏剂5-氨基乙酰丙酸(ALA),该光敏剂在正常和赘生性肿瘤中均代谢成其活性形式原卟啉IX(PpIX)。上皮组织。这项研究的目的是评估健康犬中基于ALA的PDT,以此作为治疗患有膀胱移行细胞癌的犬的前奏。方法:12只狗以0、30、60或90 mg / kg口服ALA。四小时后,处死狗,收集膀胱组织并冷冻以进行低强度荧光显微镜检查。十五只狗以0、30、60或90 mg / kg的剂量口服口服ALA,并在四小时后麻醉。用635nm的激光照射三角骨。在PDT后48小时或21天对所有的狗进行尸检。结果:PpIX荧光局限于膀胱粘膜,在肌层或浆膜中未检测到荧光。 PDT后的组织病理学损害仅限于轻度炎症。结论:健康犬在使用的剂量下口服ALA似乎具有良好的耐受性。由于PpIX荧光仅限于粘膜,因此基于ALA的PDT可能是犬下尿路肿瘤的有用治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号